The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT).
Jenny J. Ko
No relevant relationships to disclose
Wanling Xie
No relevant relationships to disclose
Daniel Yick Chin Heng
Consultant or Advisory Role - AVEO; Bayer; Novartis; Pfizer
Nils Kroeger
No relevant relationships to disclose
Jae-Lyun Lee
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer
Brian I. Rini
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Onyx; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
Jennifer J. Knox
No relevant relationships to disclose
Georg A. Bjarnason
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Lauren Christine Harshman
Consultant or Advisory Role - Novartis; Pfizer
Honoraria - Pfizer
Research Funding - Pfizer
Sumanta Kumar Pal
No relevant relationships to disclose
Takeshi Yuasa
No relevant relationships to disclose
Martin Smoragiewicz
No relevant relationships to disclose
Frede Donskov
Research Funding - Novartis
Aristotelis Bamias
No relevant relationships to disclose
Lori Wood
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
D. Scott Ernst
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Ulka N. Vaishampayan
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Sun Young Rha
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; Novartis
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer; Genentech; GlaxoSmithKline; Novartis; Onyx; Pfizer
Research Funding - Pfizer